159 related articles for article (PubMed ID: 21704462)
1. When drugs in the same controlled substance schedule differ in real-world abuse, should they be differentiated in labeling?
Dasgupta N; Henningfield JE; Ertischek MD; Schnoll SH
Drug Alcohol Depend; 2011 Dec; 119(1-2):e1-4. PubMed ID: 21704462
[TBL] [Abstract][Full Text] [Related]
2. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
Manchikanti L; Singh A
Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
[TBL] [Abstract][Full Text] [Related]
4. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
[TBL] [Abstract][Full Text] [Related]
5. Abuse of prescription drugs and the risk of addiction.
Compton WM; Volkow ND
Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S4-7. PubMed ID: 16563663
[TBL] [Abstract][Full Text] [Related]
6. Prescription drug monitoring programs and death rates from drug overdose.
Paulozzi LJ; Kilbourne EM; Desai HA
Pain Med; 2011 May; 12(5):747-54. PubMed ID: 21332934
[TBL] [Abstract][Full Text] [Related]
7. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
Wright C; Schnoll S; Bernstein D
Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
[TBL] [Abstract][Full Text] [Related]
8. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.
Schneider MF; Bailey JE; Cicero TJ; Dart RC; Inciardi JA; Parrino M; Muñoz A
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):778-90. PubMed ID: 19536784
[TBL] [Abstract][Full Text] [Related]
9. CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(1):10-3. PubMed ID: 22237030
[TBL] [Abstract][Full Text] [Related]
10. Risk management and post-marketing surveillance of CNS drugs.
Henningfield JE; Schuster CR
Drug Alcohol Depend; 2009 Dec; 105 Suppl 1():S56-64. PubMed ID: 19767155
[TBL] [Abstract][Full Text] [Related]
11. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008.
Cai R; Crane E; Poneleit K; Paulozzi L
J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):293-7. PubMed ID: 20718652
[TBL] [Abstract][Full Text] [Related]
12. The rise in prescription drug abuse: raising awareness in the dental community.
Oakley M; O'Donnell J; Moore PA; Martin J
Compend Contin Educ Dent; 2011; 32(6):14-6, 18-22; quiz 24, 36. PubMed ID: 21894872
[TBL] [Abstract][Full Text] [Related]
13. The prescription drug epidemic in the United States: a perfect storm.
Maxwell JC
Drug Alcohol Rev; 2011 May; 30(3):264-70. PubMed ID: 21545556
[TBL] [Abstract][Full Text] [Related]
14. Issues and critiques of the forthcoming risk evaluation and mitigation strategy (REMS) for opioids in pain management.
Peppin JF; Coleman JJ; Kirsh KL
Issues Law Med; 2011; 27(2):91-119. PubMed ID: 22372206
[TBL] [Abstract][Full Text] [Related]
15. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.
Pauly V; Frauger E; Pradel V; Rouby F; Berbis J; Natali F; Reggio P; Coudert H; Micallef J; Thirion X
Drug Alcohol Depend; 2011 Jan; 113(1):29-36. PubMed ID: 20692778
[TBL] [Abstract][Full Text] [Related]
16. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
[TBL] [Abstract][Full Text] [Related]
17. A pill problem: prescription drug abuse is the fastest growing form of substance abuse.
Hanson K
State Legis; 2010 Mar; 36(3):22-5. PubMed ID: 20306600
[No Abstract] [Full Text] [Related]
18. Prescription drug abuse: an epidemic dilemma.
DuPont RL
J Psychoactive Drugs; 2010 Jun; 42(2):127-32. PubMed ID: 20648908
[TBL] [Abstract][Full Text] [Related]
19. Non-medical use and abuse of commonly prescribed medications.
Riggs P
Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
[TBL] [Abstract][Full Text] [Related]
20. Addiction: part II. Identification and management of the drug-seeking patient.
Longo LP; Parran T; Johnson B; Kinsey W
Am Fam Physician; 2000 Apr; 61(8):2401-8. PubMed ID: 10794581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
